References
- Anderson, B. D., & Taphouse, V. (1981). Initial rate studies of hydrolysis and acyl migration in methylprednisolone 21-hemisuccinate and 17-hemisuccinate. Journal of Pharmaceutical Sciences, 70, 181–186., [PUBMED], [INFOTRIEVE], [CSA]
- Brzezinski, A., Rankin, G. B., Seidner, D. L., & Lashner, B. A. (1995). Use of old and new oral 5-aminosalicylic acid formulations in inflammatory bowel disease. Cleveland Clinic Journal of Medicine, 62, 317–323., [PUBMED], [INFOTRIEVE], [CSA]
- Ekstrom, G. M. (1998). Oxazolone-induced colitis in rats: effects of budesonide, cyclosporine A, and 5-aminosalicylic acid. Scandinavian Journal of Gastroenterology, 33, 174–179., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Erdmann, L., & Uhrich, K. E. (2000). Synthesis and degradation characteristics of salicylic acid-derived poly(anhydride-esters). Biomaterials, 21, 1941–1946., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Galvez, J., Garrido, M., Merlos, M., Torres, M. I., & Zarzuelo, A. (2000). Intestinal anti-inflammatory activity of UR-12746, a novel 5-ASA conjugate, on acute and chronic experimental colitis in the rat. British Journal of Pharmacology, 130, 1949–1959., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kinget, R., Kalala, W., Vervoort, L., & van den Mooster, G. (1998). Colonic drug targeting. Journal of Drug Targeting, 6, 129–149., [PUBMED], [INFOTRIEVE], [CSA]
- Kleessen, B., Kroesen, A. J., Buhr, H. J., & Blaut, M. (2002). Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scandinavian Journal of Gastroenterology, 37, 1034–1041., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Klotz, U. (1985). Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid. Clinical Pharmacokinetics, 10, 285–302., [PUBMED], [INFOTRIEVE], [CSA]
- Lamprecht, A., Schafer, U., & Lehr, C. M. (2000a). Site specific targeting of microparticles to the inflamed colonic mucosa: a novel approach to the treatment of inflammatory bowel disease. Proceedings of the International Symposium on Controlled Release of Bioactive Materials, 27, 480–481., [CSA]
- Lamprecht, A., Schafer, U., & Lehr, C. M. (2000b). Microparticle targeting to the inflamed colonic mucosa for the treatment of inflammatory bowel disease: in vivo results from rat. AAPS PharmSciences, 2(S1), , Abstract 1930. [CSA]
- Lamprecht, A., Ubrich, N., Yamamoto, H., Schafer, U., Takeuchi, H., Lehr, C. M., Maincent, P., & Kawashima, Y. (2001a). Design of rolipram-loaded nanoparticles: comparison of two preparation methods. Journal of Controlled Release, 71, 297–306., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lamprecht, A., Schafer, U., & Lehr, C. M. (2001b). Size-dependent bioadehesion of micro- and nanoparticles to the inflamed colonic mucosa. Pharmaceutical Research, 18, 788–793., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lamprecht, A., Ubrich, N., Yamamoto, H., Schafer, U., Takeuchi, H., Maincent, P., Kawashima, Y., & Lehr, C. M. (2001c). Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. Journal of Pharmacology and Experimental Therapeutics, 299, 775–781., [PUBMED], [INFOTRIEVE], [CSA]
- Larouche, J., Morais, J., Picard, M., Lambert, C., Spenard, J., Landriault, H., Kennedy, G., & Poitras, P. (1995). Release of 5-ASA from Pentasa in patients with Crohn's disease of the small intestine. Alimentary Pharmacology & Therapeutics, 9, 315–320., [CSA]
- McLeod, A. D., Friend, D. R., & Tozer, T. N. (1993). Synthesis and chemical stability of glucocorticoid-dextran esters: potential prodrugs for colon-specific delivery. International Journal of Pharmaceutics, 92, 104–114., [CSA], [CROSSREF]
- McLeod, A. D., Friend, D. R., & Tozer, T. N. (1994). Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents. Journal of Pharmaceutical Sciences, 83, 1284–1288., [PUBMED], [INFOTRIEVE], [CSA]
- Mehvar, R., Dann, R. O., & Hoganson, D. A. (2000). Kinetics of hydrolysis of dextran-methylprednisolone succinate, a macromolecular prodrug of methylprednisolone, in rat blood and liver lysosomes. Journal of Controlled Release, 68, 53–61., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Nakase, H., Okazaki, K., Tabata, Y., Uose, S., Ohana, M., Uchida, K., Matsushima, Y., Kawanami, C., Oshima, C., Ikada, Y., & Chiba, T. (2000). Development of an oral drug delivery system targeting immune-regulating cells in experimental inflammatory bowel disease: a new therapeutic strategy. Journal of Pharmacology and Experimental Therapeutics, 292, 15–21., [PUBMED], [INFOTRIEVE], [CSA]
- Pallone, F., Blanco Gdel, V., Vavassori, P., Monteleone, I., Fina, D., & Monteleone, G. (2003). Genetic and pathogenetic insights into inflammatory bowel disease. Current Gastroenterology Reports, 5, 487–492., [PUBMED], [INFOTRIEVE], [CSA]
- Shimoda, J., Onishi, H., & Machida, Y. (2001). Bioadhesive characteristics of chitosan microspheres to the mucosa of rat small intestine. Drug Development and Industrial Pharmacy, 27, 567–576., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tabata, Y., & Ikada, Y. (1988). Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials, 9, 356–362., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tabata, Y., Inoue, Y., & Ikada, Y. (1996). Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres. Vaccine, 14, 1677–1685., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Takishima, J., Onishi, H., & Machida, Y. (2002). Prolonged intestinal absorption of cephradine with chitosan-coated ethylcellulose microparticles in rats. Biological & Pharmaceutical Bulletin, 25, 1498–1502., [CSA], [CROSSREF]
- Tozaki, H., Odoriba, T., Okada, N., Fujita, T., Terabe, A., Suzuki, T., Okabe, S., Muranishi, S., & Yamamoto, A. (2002). Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats. Journal of Controlled Release, 82, 51–61., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Watts, P. J., & Illum, L. (1997). Colonic drug delivery. Drug Development and Industrial Pharmacy, 23, 893–913., [CSA]
- Watts, P. J., Barrow, L., Steed, K. P., Wilson, C. G., Spiller, R. C., Melia, C. D., & Davies, M. C. (1992). The transit rate of different sized model dosage forms through the human colon and the effects of a lactulose-induced catharsis. International Journal of Pharmaceutics, 87, 215–221., [CSA], [CROSSREF]
- Yano, H., Hirayama, F., Kamada, M., Arima, H., & Uekama, K. (2002). Colon-specific delivery of prednisolone-appended alpha-cyclodextrin conjugate: alleviation of systemic side effect after oral administration. Journal of Controlled Release, 79, 103–112., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]